Loading clinical trials...

Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries | Clinical Trials | Clareo Health

UNKNOWNNA

Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries

Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries: An Equivalent Parallel Randomized Controlled Trial

NCT05554952•Minia University

View on ClinicalTrials.gov

Summary

The aim of the current randomized controlled trial is to evaluate clinical and radiographic outcomes of indirect pulp capping and pulpotomy with MTA in treatment of primary teeth with deep caries over a 12-month follow-up period.

Detailed Description

Output patients coming to Pediatric dentistry department Minia University, selected randomly to evaluate clinical and radiographic outcomes of indirect pulp capping and pulpotomy with MTA in treatment of primary teeth with deep caries over a 12-month follow-up period an equivalent parallel randomized controlled trial

Eligibility

Age

3 - 6 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•\- 4 to 6 years old patients presented with deep carious lesions in primary molars.
•Apparently healthy children (ASA I, II classification).
•Co-operative children (Rating 3 \& 4 according to Frankle classification)

Exclusion Criteria

•A) Clinical:
•Non restorable primary molars.
•Presence of clinical pathology.
•Presence of mobility or tenderness to percussion.
•* Spontaneous pain.
•B) Radiographic:
•Pre-operative radiographs showed external or internal root resorption.
•Presence of furcal radiolucency.
•Presence of periapical radiolucency or widened periodontal ligament space
•More than one-third root resorption detected.

Locations (2)

Minia University

Minya, Egypt

Minia University

Minya, Egypt

Key Dates

Start Date

November 1, 2021

Primary Completion Date

November 1, 2023

Completion Date

November 1, 2023

Last Updated

September 26, 2022

Enrollment

100

ACTUAL participants

Conditions

Indirect Pulp CappingPulpotomy

Interventions

MTA

COMBINATION_PRODUCT

Effectiveness of Pulpotomy in Symptomatic Permanent Teeth With Deep Caries Lesions

NCT06918639

Irreversible PulpitisPulpotomy of Permanent Molars

View study

RECRUITINGNA

Clinical and Radiographic Evaluation of Pulpotomies in Primary Molars Using Tricalcium Silicate Cements

NCT04902495

Primary Molar Pulpotomy

View study

COMPLETED

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 26, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Indirect Pulp Capping Versus Pulpotomy With MTA for Treatment of Primary Molars With Deep Caries

Inclusion Criteria

Exclusion Criteria

Effectiveness of Pulpotomy in Symptomatic Permanent Teeth With Deep Caries Lesions

Clinical and Radiographic Evaluation of Pulpotomies in Primary Molars Using Tricalcium Silicate Cements

Outcome Following Use of Different Concentrations of NaOCl as Wound Lavage and Hemostatic Agent in Partial Pulpotomy

Clinical Success of Indirect Pulp Capping: 1-Year Follow-Up

Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain

Evaluation of Hemostasis Time on Partial Pulpotomy in Teeth With Clinical Signs Indicative of Irreversible Pulpitis